Parade on MSN1mon
New Research Finds That a Simple, At-Home Test Could Be Our Best Bet for Early Dementia Detection—Here’s What It Is
Here's everything you need to know about the SAGE test for dementia. Related: Everything You Need to Know About Cleveland ...
pharmaphorum11d
Sage takes another hit as Alzheimer's drug is canned
News of the outcome of the 12-week LIGHTWAVE study, which included 174 patients with MCI or mild dementia due to Alzheimer's, added to the pressure on Sage's ... WAIS-IV Coding Test score at ...
Self-administered test in primary care offices found to increase early diagnosis of cognitive disorders
Primary care providers often are the first to identify and evaluate patients with neurocognitive disorders such as mild ...
MarketWatch1mon
Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Sage Therapeutics Inc.’s stock tumbled 5% Tuesday, after the company said it would cease development of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease due ...
Business Wire1mon
Sage Therapeutics Announces Topline Results from the Phase 2 LIGHTWAVE Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment and Mild Dementia in ...
placebo-controlled study to evaluate the effects of dalzanemdor (SAGE-718) in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s Disease (AD). The LIGHTWAVE ...